hero-default-mask hero-default-mask
Home Services Immuno-Oncology

Our custom Immuno-Oncology services

Your drug discovery pipeline

The best route to clinic

Immuno-Oncology is an exciting and progressing area of research that uses manipulation of the immune system to successfully target cancer.


Aquila can help you understand the immunomodulatory effects of your drug candidates within the tumour microenvironment and/or in combination with other immune modulators, efficiently progressing your route to clinic.

We have extensive in vitro immunology, pre-clinical immuno-oncology and specialist multiplex histology experience. Our suite of available immuno-oncology services and assays can be specifically tailored to your project:

  • Exhausted CD4+ T Cell assay
  • Human PBMC & T Cell Activation assays
  • Human Mixed Lymphocyte Reactions
  • Human DC, Macrophage and Co-culture assays
  • T Cell Killing assay

Please get in touch to discuss how Aquila can help you with your immuno-oncology, immunology or specialist histology research needs.

The immune checkpoint space was until recently devoid of focused CRO activity. Aquila BioMedical has sought to become a driving force in this area and the result is a terrific suite of assays in both mouse and human cell systems, with multiple readouts, solid antibody benchmarking and careful controls.

Paul Rennert, CEO, SugarCone Biotech

Our expertise

We have extensive experience of providing immunological CRO services to clients discovering and developing treatments for cancer, autoimmune diseases, and in regenerative medicine.

Research & Development

Our vision is to be a global leader in innovative contract research.

About Aquila BioMedical

We offer preclinical contract research based on world-leading expertise in immunology, immuno-oncology and specialist histology